Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-001348

PRESIDENT AND COO sold 10,000 shares at an average $371.05 ($3,710,499)

  • PRESIDENT AND COO acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-18 Exercise or conversion : show line 1 in the form 10b5-1 +7,500 $111.00 $832,500 7,500 I
2025-02-18 Sale : show line 2 in the form 10b5-1 −100 $366.19 $36,619 7,400 I
2025-02-18 Sale : show line 3 in the form 10b5-1 −600 $368.32 $220,994 6,800 I
2025-02-18 Sale : show line 4 in the form 10b5-1 −1,432 $369.65 $529,343 5,368 I
2025-02-18 Sale : show line 5 in the form 10b5-1 −1,068 $370.70 $395,911 4,300 I
2025-02-18 Sale : show line 6 in the form 10b5-1 −2,351 $371.47 $873,318 1,949 I
2025-02-18 Sale : show line 7 in the form 10b5-1 −1,549 $372.63 $577,196 400 I
2025-02-18 Sale : show line 8 in the form 10b5-1 −400 $373.67 $149,469 0 I
Open-market sales · 10,000 sh · avg $371.05 · $3,710,499

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-02-18 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option −7,500 $111.00 2028-03-15 7,500 14,679 I
2025-02-18 Exercise or conversion : show line 17 in the form 10b5-1 Stock Options −2,500 $111.00 2028-03-15 2,500 7,000 I
Loading xslF345X05/primarydocument.xml…